EGFR and breast carcinoma: The STAT5 pathway has been shown to mediate PRLR activity and regulate mammary gland development, differentiation, and proliferation [26,34], whereas EGFR is a central growth factor pathway in mammary gland development and a subset of breast cancers [35].